CAMBRIDGE, Mass., Oct. 27 /PRNewswire-FirstCall/ -- Biopure Corporation
(Nasdaq: BPUR) today announced that company President and CEO Zafiris G.
Zafirelis will present at two upcoming investor conferences:
-- MASS Opportunities: A Biotechnology Investment Conference, Thursday,
November 3, 2005, 1:20 p.m. eastern time (ET), at the Logan Airport
Hilton, Boston, Mass. More information about this conference is
available at http://www.massopps.com.
-- Rodman & Renshaw Techvest 7th Annual Healthcare Conference on Tuesday,
November 8, 2005, 11:55 a.m. ET, at the New York Palace Hotel, New
York City. More information about this conference is available at
http://www.rodmanandrenshaw.com.
A live webcast of the presentations will be available online via the
Investor Relations section of Biopure's web site at http://www.biopure.com.
An archive of the webcast will be available for at least two weeks.
Biopure Corporation
Biopure Corporation develops and manufactures intravenously administered
pharmaceuticals, called oxygen therapeutics, that deliver oxygen to the body's
tissues. The company is developing Hemopure(R) [hemoglobin glutamer -- 250
(bovine)], or HBOC-201, for a potential indication in cardiovascular ischemia
and, in collaboration with the U.S. Naval Medical Research Center, for an out-
of-hospital trauma indication. The product is approved in South Africa for
treating surgery patients who are acutely anemic and for eliminating, delaying
or reducing allogeneic red blood cell transfusions in these patients. Hemopure
has not been approved for sale in other jurisdictions, including the United
States or the European Union. Biopure's veterinary product Oxyglobin(R)
[hemoglobin glutamer -- 200 (bovine)], or HBOC-301, the only oxygen
therapeutic approved by the U.S. Food and Drug Administration and the European
Commission, is indicated for the treatment of anemia in dogs.
Contact: Douglas Sayles
(617) 234-6826
Biopure Corporation
IR@biopure.com
SOURCE Biopure Corporation
 back to top
Company News On-Call:
http://www.prnewswire.com/comp/131224.html
Related links:
http://www.biopure.com
http://www.rodmanandrenshaw.com http://www.massopps.com
CONTACT:
Douglas Sayles of Biopure Corporation,
+1-617-234-6826, IR@biopure.com
|
